Julie Krop
CIK 1643127 · Chief Medical Officer · last filed 2026-06-03
Julie Krop is a Chief Medical Officer who has filed 24 SEC Form 4 insider transactions across 3 companies since 2015. The most recent filing, for DMAC, was dated Jun 3, 2026. Across all open-market trades the lifetime net is −$168.4K, making them a net seller over the disclosed history.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$0
3
24
-$168.4K
Holdings By Company
Recent Filings
24 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-06-03 | DMAC | Grant (A) | — | $0 | EDGAR |
| 2025-11-03 | DMAC | Grant (A) | — | $0 | EDGAR |
| 2025-06-12 | AQST | Grant (A) | — | $0 | EDGAR |
| 2024-06-21 | AQST | Grant (A) | — | $0 | EDGAR |
| 2023-06-23 | AQST | Grant (A) | — | $0 | EDGAR |
| 2022-06-24 | AQST | Grant (A) | — | $0 | EDGAR |
| 2021-06-17 | AQST | Grant (A) | — | $0 | EDGAR |
| 2021-03-15 | AQST | Grant (A) | — | $0 | EDGAR |
| 2020-03-04 | AMAG PHARMACEUTICALS, INC. (AMAG) Delisted | Tax (F) | −1,333 | -$10.3K | EDGAR |
| 2020-02-25 | AMAG PHARMACEUTICALS, INC. (AMAG) Delisted | Tax (F) | −2,022 | -$18.4K | EDGAR |